Article Details

Abbott receives FDA OK for over-the-counter glucose monitor | MedTech Dive

Retrieved on: 2024-06-03 16:49:06

Tags for this article:

Click the tags to see associated articles and topics

Abbott receives FDA OK for over-the-counter glucose monitor | MedTech Dive. View article details on hiswai:

Summary

The article discusses Abbott's FDA clearance for its over-the-counter glucose monitor, Lingo, highlighting its potential competition with Dexcom in the MedTech market. It primarily relates to CGM technology, insulin management, and diabetes care.

Article found on: www.medtechdive.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up